OneMedNet CorporationONMDNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
-15.45%
↓ 307% vs avg
Percentile
P13
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
7.46%
Historical baseline
PeriodValue
Q3 2025-15.45%
Q2 20259.77%
Q1 20252.35%
Q4 202414.09%
Q3 2024-22.19%
Q2 2024-13.93%
Q1 2024-10.73%
Q4 202323.08%
Q3 2023-30.05%
Q2 2023-0.52%
Q1 2023140.16%
Q4 20220.00%
Q3 20220.00%
Q2 202239.04%
Q1 20224.57%
Q4 2021-13.46%
Q3 20210.00%